Effect of body mass index on the survival benefit of liver transplantation

Liver Transplantation

Volumn 13, Issue 12, 2007, Pages 1678-1683

  Pelletier, Shawn J ^a   Schaubel, Douglas E ^b,c   Wei, Guanghui ^b   Englesbe, Michael J ^a   Punch, Jeffrey D ^a   Wolfe, Robert A ^c,d   Port, Friedrich K ^c,d   Merion, Robert M ^a,c  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^b UNIVERSITY OF MICHIGAN   (United States)

^c Scientific Registry of Transplant Recipients   (United States)

^d ARBOR RESEARCH COLLABORATIVE FOR HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; BODY MASS; BODY WEIGHT; COHORT ANALYSIS; CONTROLLED STUDY; DEATH; FEMALE; GRAFT RECIPIENT; HAZARD RATIO; HIGH RISK PATIENT; HUMAN; LIVER CIRRHOSIS; LIVER FAILURE; LIVER NECROSIS; LIVER TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; MORBID OBESITY; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; PROPORTIONAL HAZARDS MODEL; RETROSPECTIVE STUDY; STATISTICAL SIGNIFICANCE; SURGICAL MORTALITY; SURVIVAL RATE; TREATMENT CONTRAINDICATION; UNDERWEIGHT;

ADULT; BODY MASS INDEX; FEMALE; FOLLOW-UP STUDIES; HUMANS; LIVER FAILURE; LIVER TRANSPLANTATION; MALE; MIDDLE AGED; OBESITY; PROPORTIONAL HAZARDS MODELS; RETROSPECTIVE STUDIES; RISK ASSESSMENT; THINNESS; TIME FACTORS; TREATMENT OUTCOME; WAITING LISTS;

EID: 37549020703     PISSN: 15276465     EISSN: 15276473     Source Type: Journal    
DOI: 10.1002/lt.21183     Document Type: Article

References (19)

1. Mokdad AH, Bowman BA, Ford ES, Vinicor F, Marks JS, Koplan JP. The continuing epidemics of obesity and diabetes in the United States. JAMA 2001;286:1195-1200.
2. Mokdad AH, Serdula MK, Dietz WH, Bowman BA, Marks JS, Koplan JP. The spread of the obesity epidemic in the United States, 1991-1998. JAMA 1999;282:1519-1522.
3. Nair S, Verma S, Thuluvath PJ. Obesity and its effect on survival in patients undergoing orthotopic liver transplantation in the United States. Hepatology 2002;35:105-109.
4. Kaafarani HM, Itani KM, Thornby J, Berger DH. Thirty-day and one-year predictors of death in noncardiac major surgical procedures. Am J Surg 2004;188:495-499.
5. Murray KF, Carithers RL Jr. AASLD practice guidelines: evaluation of the patient for liver transplantation. Hepatology 2005;41:1407-1432.
6. Burdick RA, Leichtman AB, Bragg JL, Cibrik DM, Dykstra DM, Port FK. Obesity is associated with poorer outcomes in cadaveric renal transplant recipients but not in cadaveric liver transplant recipients [Abstract]. Am J Transplant 2002;2[S3]:381.
7. Nair S, Cohen DB, Cohen MP, Tan H, Maley W, Thuluvath PJ. Postoperative morbidity, mortality, costs, and long-term survival in severely obese patients undergoing orthotopic liver transplantation. Am J Gastroenterol 2001;96:842-845.
8. Mazuelos F, Abril J, Zaragoza C, Rubio E, Moreno JM, Turrion VS, et al. Cardiovascular morbidity and obesity in adult liver transplant recipients. Transplant Proc 2003;35: 1909-1910.
9. Braunfeld MY, Chan S, Pregler J, Neelakanta G, Sopher MJ, Busuttil RW, et al. Liver transplantation in the morbidly obese. J Clin Anesth 1996;8:585-590.
10. Hade AM, Shine AM, Kennedy NP, McCormick PA. Both under-nutrition and obesity increase morbidity following liver transplantation. Ir Med J 2003;96:140-142.
11. Sawyer RG, Pelletier SJ, Pruett TL. Increased early morbidity and mortality with acceptable long-term function in severely obese patients undergoing liver transplantation. Clin Transplant 1999;13:126-130.
12. Merion RM, Schaubel DE, Dykstra DM, Freeman RB, Port FK, Wolfe RA. The survival benefit of liver transplantation. Am J Transplant 2005;5:307-313.
13. Pirsch JD, Armbrust MJ, Knechtle SJ, D'Alessandro AM, Sollinger HW, Heisey DM, et al. Obesity as a risk factor following renal transplantation. Transplantation 1995;59: 631-633.
14. NHLBI Obesity Education Initiative Expert Panel on the Identification, Evaluation, and Treatment of Overweight and Obesity in Adults. Clinical guidelines on the identification, evaluation, and treatment of overweight and obesity in adults - the evidence report. Obes Res 1948;6:51S-209S.
15. 2005 Annual Report of the U.S. Organ Procurement and Transplantation Network and the Scientific Registry for Transplant Recipients: transplant data 1995-2004: Department of Health and Human Services, Health Resources and Services Administration, Office of Special Programs, Division of Transplantation, Rockville, MD; United Network for Organ Sharing, Richmond, VA; University Renal Research and Education Association, Ann Arbor, MI, 2006. Chapter VI: Liver and Intestine Transplantation in the United States, 1995-2004.
16. Gibbs J, Cull W, Henderson W, Daley J, Hur K, Khuri SF. Preoperative serum albumin level as a predictor of operative mortality and morbidity: results from the National VA Surgical Risk Study. Arch Surg 1999;134:36-42.
17. Galanos AN, Pieper CF, Kussin PS, Winchell MT, Fulkerson WJ, Harrell FE Jr, et al. Relationship of body mass index to subsequent mortality among seriously ill hospitalized patients. SUPPORT Investigators. The study to understand prognoses and preferences for outcome and risks of treatments. Crit Care Med 1997;25:1962-1968.
18. Florath I, Albert AA, Rosendahl UP, Hassanein WM, Bauer S, Ennker IC, et al. Body mass index: a risk factor for 30-day or six-month mortality in patients undergoing aortic valve replacement? J Heart Valve Dis 2006;15:336-344.
19. Rapp-Kesek D, Stahle E, Karlsson TT. Body mass index and albumin in the preoperative evaluation of cardiac surgery patients. Clin Nutr 2004;23:1398-1404.